AUPH
Aurinia Pharmaceuticals Inc.
NASDAQHealthcareBiotechnologyCA
Rating:A-
Company Profile
CEO
Kevin C. Tang
IPO Date
2014-09-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
CA
Aurinia Pharmaceuticals Inc.
CEO
Kevin C. Tang
IPO Date
2014-09-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
CA
| 116,144 |
| $0.00 |
| 20 May 2026 | Hearne Michael S | Chief Financial Officer | A-Award | Acquired | 70,230 | $15.28 |
| 20 May 2026 | Cole Ryan | Chief Operating Officer | A-Award | Acquired | 116,144 | $0.00 |
| 20 May 2026 | Cole Ryan | Chief Operating Officer | A-Award | Acquired | 70,230 | $15.28 |
| 2 Apr 2026 | Cole Ryan | officer | Disposed | 0 | $0.00 |
| 2 Apr 2026 | Hearne Michael S | officer | Disposed | 0 | $0.00 |
| 10 Mar 2026 | Keenan Greg | SVP, Chief Medical Officer | F-InKind | Disposed | 8,069 | $14.32 |
| 3 Mar 2026 | TANG KEVIN | director | P-Purchase | Acquired | 300,000 | $13.90 |
| 3 Mar 2026 | TANG KEVIN | director | P-Purchase | Acquired | 214,839 | $14.12 |